Published by: Wolters Kluwer
2022 article number: 195
Print ISSN: 0959-4973
Online ISSN: 1473-5741
Journal number of registered peer reviews: 0
Journal number of reviewers: 2
Anti-Cancer Drugs Journal Editors
| Editor | Affiliation |
|---|---|
| Paul Dent | Department of Biochemistry, Virginia Commonwealth University, VCU Massey Cancer Center, 401 College Street, Richmond VA 23298-0035, USA |
Disclaimer
Anti-Cancer Drugs journal published by Lippincott Williams & Wilkins Ltd. information might be outdated. In such case, we kindly request that you reach out to the Reviewer Credits team to facilitate the necessary updates to the information presented. If you hold an editorial position with the journal or the publisher, we invite you to become a registered member of Reviewer Credits. Registration is free and allows you to curate a customized journal showcase page, ensuring that the most accurate and recent data is available. Your engagement in keeping your journal’s information up-to-date is invaluable and greatly appreciated by the peer review community.
For more information on the benefits Reviewer Credits offers to your journal, click here: What we offer to journals.